INS and glucose measurement: SR4 treatment also improved glycemic control and glucose tolerance in HFD obese mice (as well in type 2 diabetic db/db mice, data not shown) as evidenced by significant improvement in non-fasting glucose levels, glucose tolerance tests, and decrease in circulating plasma insulin levels.